Revvity, ALSU-PAKT-B10K, AlphaLISA Human and Mouse Phospho-AKT1/2/3 (Ser473) Detection Kit, 10,000 Assay Points

Overview
The AKT serine/threonine kinase, also known as protein kinase B (PKB), is a crucial component of the PI3K/AKT/mTOR signaling pathway. In humans, there are three AKT isoforms (AKT1, AKT2, and AKT3) encoded by separate genes. AKT plays a central role in various cellular processes, including cell survival, proliferation, metabolism, and angiogenesis. Activation of AKT occurs through phosphorylation at two key sites: Thr308 and Ser473. The phosphorylation of Ser473 is particularly important for full activation of AKT and its downstream signaling. AKT signaling is frequently dysregulated in various diseases, especially cancer, where hyperactivation of the pathway contributes to tumor growth, metastasis, and therapy resistance.
The AlphaLISA SureFire Ultra Human and Mouse Phospho-AKT1/2/3 (Ser473) Detection Kit is a sandwich immunoassay designed for the quantitative detection of phosphorylated AKT (Ser473) in cellular lysates, using Alpha technology
Formats:

The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

Cell and tissue lysates
Antibody modulators
Biotherapeutic antibodies

Alpha SureFire kits can be used for:

Cellular kinase assays
Receptor activation studies
Screening
How it works
Phospho-AlphaLISA SureFire Ultra assay principle

The Phospho-AlphaLISA SureFire Ultra assay measures a protein target when phosphorylated at a specific residue.

The assay uses two antibodies which recognize the phospho epitope and a distal epitope on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of phosphorylated protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of phosphoprotein present in the sample.

 

Phospho-AlphaLISA SureFire Ultra two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Phospho-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

Phospho-AlphaLISA SureFire Ultra one-plate assay protocol

Detection of Phosphorylated target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
Application-Cell Signaling
Automation Compatible-Yes
Brand-AlphaLISA SureFire Ultra
Cellular or Signaling Pathway-PI3K/Akt/mTOR
Detection Modality-Alpha
Lysis Buffer Compatibility-Lysis Buffer
Molecular Modification-Phosphorylation
Product Group-Kit
Sample Volume-10 µL
Shipping Conditions-Shipped in Blue Ice
Target-Akt1/2/3
Target Class-Phosphoproteins
Target Species-Human Mouse
Technology-Alpha
Therapeutic Area-Cardiovascular Central Nervous System Metabolic
Unit Size-10,000 assay points